Signal from the log
Sava
36 M$ · Series B · United Kingdom · Medtech
Sava, issue de l'Imperial College de Londres, met au point un capteur porté sur la peau qui mesure le glucose en continu avec des microcapteurs dix fois plus courts que le filament des capteurs actuels. Levée menée par Ascensia Diabetes Care, qui distribuera le capteur en Europe s'il obtient le marquage CE.
Article
Announced on , logged by the watch of 9 October 2026.
- Operation
- Funding round
- Announced amount
- 36 M$
- Stage
- Series B
- Country
- United Kingdom
- Sector
- Medtech
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Ascensia Diabetes Care , with Balderton , Norrsken VC , Simplyhealth Ventures , JamJar Investments , Pentland Ventures
Provenance
Logged on 9 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.